치과 임플란트 시장 규모, 점유율, 동향 분석 보고서 : 표면처리 유형별, 재료별, 설계별, 지역별, 부문별 예측(2025-2033년)

Dental Implants Market Summary

The global dental implants market size was estimated at USD 5.16 billion in 2024 and is projected to reach USD 11.02 billion by 2033, growing at a CAGR of 8.92% from 2025 to 2033. The dental implants industry is driven by increasing demand for precise and advanced implant solutions, rising prevalence of tooth loss and oral disorders, and continuous innovations in implant materials and surface technologies.

Growing awareness of oral health, expanding dental tourism, and advancements in surgical techniques enhance treatment outcomes and patient satisfaction, fueling market growth. In addition, digital implant planning and guided surgery systems improve procedural accuracy, reduce treatment time, and increase overall efficiency.The growing prevalence of oral disorders, including tooth loss, tooth decay, and tooth extraction, is anticipated to propel the demand for dental implants. The data published by the WHO in March 2025 reports that approximately 7% of adults aged 20 and above, and around 23% of those aged 60 and above, experience complete tooth loss, underscoring the need for implants. The increasing burden of oral diseases, including cavities, tooth loss, and gum disease, is expected to raise the demand for dental implants significantly.

Furthermore, the burden of tooth loss is significant among the older population, which underscores the growing demand for dental implants among these patients. In addition, supportive policies contribute to the increased adoption of dental implants. For instance, a study published by the National Library of Medicine in September 2024 found that expanding dental care coverage for older adults in Korea led to a 13.5% increase in partial denture use and a 60.5% rise in dental implants among individuals aged 65 and older. Therefore, these factors, along with the rising prevalence of dental disorders in this demographic, are expected to drive market growth.

Global Dental Implant Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global dental implants market report based on surface treatment type, material, design, and region:

• Surface Treatment Type Outlook (Revenue, USD Million, 2021 - 2033)
• SLA and SLActive
• Anodized Surfaces
• Nano-Textured Surfaces
• Others
• Material Outlook (Revenue, USD Million, 2021 - 2033)
• Titanium
• Zirconia
• Design Outlook (Revenue, USD Million, 2021 - 2033)
• Tapered
• Parallel-Walled
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Content

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Surface Treatment Type
  • 1.1.2. Material
  • 1.1.3. Design
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Dental Implants Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising burden of dental disorders
    • 3.2.1.2. Expanding applications of dental implants in various therapeutic areas
    • 3.2.1.3. Introduction of novel implants
    • 3.2.1.4. Increasing demand for prosthetics
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of dental implant procedures
    • 3.2.2.2. Adverse effects associated with dental implants
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Increasing number of clinical trials
    • 3.2.3.2. Expansion opportunities in emerging economies
    • 3.2.3.3. Advancements in surface technology
    • 3.2.3.4. Innovations in tapered implants
    • 3.2.3.5. Technological advancements
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Product recalls
    • 3.2.4.2. Shortage of skilled professionals
• 3.3. Dental Implants Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Dental Implants Market: Surface Treatment Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Dental Implants Market Surface Treatment Type Movement Analysis
• 4.3. Global Dental Implants Market Size & Trend Analysis, by Surface Treatment Type 2021 to 2033 (USD Million)
• 4.4. SLA and SLActive
  • 4.4.1. SLA and SLActive market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.5. Anodized Surfaces
  • 4.5.1. Anodized surfaces market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.6. Nano-Textured Surfaces
  • 4.6.1. Nano-textured surfaces market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.7. Others
  • 4.7.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Dental Implants Market: Material Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Dental Implants Market Material Movement Analysis
• 5.3. Global Dental Implants Market Size & Trend Analysis, by Material, 2021 to 2033 (USD Million)
• 5.4. Titanium
  • 5.4.1. Titanium market estimates and forecast 2021 to 2033 (USD Million)
• 5.5. Zirconium
  • 5.5.1. Zirconium market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Dental Implants Market: Design Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Dental Implants Market Design Movement Analysis
• 6.3. Global Dental Implants Market Size & Trend Analysis, by Design, 2021 to 2033 (USD Million)
• 6.4. Tapered
  • 6.4.1. Tapered market estimates and forecast 2021 to 2033 (USD Million)
• 6.5. Parallel Walled
  • 6.5.1. Parallel walled market estimates and forecast 2021 to 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Dental Implants Market: Regional Estimates & Trend Analysis By Design, By Material and By Surface Treatment Type

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 7.3. North America
  • 7.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Competitive scenario
    • 7.3.2.3. Regulatory framework
    • 7.3.2.4. Reimbursement scenario
    • 7.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Competitive scenario
    • 7.3.3.3. Regulatory framework
    • 7.3.3.4. Reimbursement scenario
    • 7.3.3.5. Canada market estimates and forecasts, 2021 - 2033
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Competitive scenario
    • 7.3.4.3. Regulatory framework
    • 7.3.4.4. Reimbursement scenario
    • 7.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
• 7.4. Europe
  • 7.4.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory framework
    • 7.4.2.4. Reimbursement scenario
    • 7.4.2.5. UK market estimates and forecasts, 2021 - 2033
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory framework
    • 7.4.3.4. Reimbursement scenario
    • 7.4.3.5. Germany market estimates and forecasts, 2021 - 2033
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Regulatory framework
    • 7.4.4.4. Reimbursement scenario
    • 7.4.4.5. France market estimates and forecasts, 2021 - 2033
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Competitive scenario
    • 7.4.5.3. Regulatory framework
    • 7.4.5.4. Reimbursement scenario
    • 7.4.5.5. Italy market estimates and forecasts, 2021 - 2033
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Competitive scenario
    • 7.4.6.3. Regulatory framework
    • 7.4.6.4. Reimbursement scenario
    • 7.4.6.5. Spain market estimates and forecasts, 2021 - 2033
  • 7.4.7. Denmark
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Competitive scenario
    • 7.4.7.3. Regulatory framework
    • 7.4.7.4. Reimbursement scenario
    • 7.4.7.5. Denmark market estimates and forecasts, 2021 - 2033
  • 7.4.8. Sweden
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Competitive scenario
    • 7.4.8.3. Regulatory framework
    • 7.4.8.4. Reimbursement scenario
    • 7.4.8.5. Sweden market estimates and forecasts, 2021 - 2033
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Competitive scenario
    • 7.4.9.3. Regulatory framework
    • 7.4.9.4. Reimbursement scenario
    • 7.4.9.5. Norway market estimates and forecasts, 2021 - 2033
• 7.5. Asia Pacific
  • 7.5.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. Japan market estimates and forecasts, 2021 - 2033
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. India market estimates and forecasts, 2021 - 2033
  • 7.5.4. China
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. China market estimates and forecasts, 2021 - 2033
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory framework
    • 7.5.5.4. Reimbursement scenario
    • 7.5.5.5. South Korea market estimates and forecasts, 2021 - 2033
  • 7.5.6. Australia
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory framework
    • 7.5.6.4. Reimbursement scenario
    • 7.5.6.5. Australia market estimates and forecasts, 2021 - 2033
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Competitive scenario
    • 7.5.7.3. Regulatory framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. Thailand market estimates and forecasts, 2021 - 2033
• 7.6. Latin America
  • 7.6.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Brazil market estimates and forecasts, 2021 - 2033
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Argentina market estimates and forecasts, 2021 - 2033
• 7.7. MEA
  • 7.7.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. South Africa market estimates and forecasts, 2021 - 2033
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. UAE market estimates and forecasts, 2021 - 2033
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Global Key company market share analysis, 2024
  • 8.3.4. Biohorizons
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
    • 8.3.4.5. SWOT analysis
    • 8.3.4.6. Future developments/R&D trends
  • 8.3.5. Nobel Biocare (Envista)
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
    • 8.3.5.5. SWOT analysis
    • 8.3.5.6. Future developments/R&D trends
  • 8.3.6. Zimvie Inc.
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
    • 8.3.6.5. SWOT analysis
    • 8.3.6.6. Future developments/R&D trends
  • 8.3.7. Osstem Implant
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
    • 8.3.7.5. SWOT analysis
    • 8.3.7.6. Future developments/R&D trends
  • 8.3.8. Institut Straumann AG
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
    • 8.3.8.5. SWOT analysis
    • 8.3.8.6. Future developments/R&D trends
  • 8.3.9. Bicon, LLC
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
    • 8.3.9.5. SWOT analysis
    • 8.3.9.6. Future developments/R&D trends
  • 8.3.10. Leader Medica
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
    • 8.3.10.5. SWOT analysis
    • 8.3.10.6. Future developments/R&D trends
  • 8.3.11. Dentsply Sirona
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
    • 8.3.11.5. SWOT analysis
    • 8.3.11.6. Future developments/R&D trends
  • 8.3.12. Dentis
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
    • 8.3.12.5. SWOT analysis
    • 8.3.12.6. Future developments/R&D trends
  • 8.3.13. Dentium Co, Ltd.
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
    • 8.3.13.5. SWOT analysis
    • 8.3.13.6. Future developments/R&D trends
  • 8.3.14. T-Plus Implant Tech Co., Ltd.
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives
    • 8.3.14.5. SWOT analysis
    • 8.3.14.6. Future developments/R&D trends
  • 8.3.15. Kyochera Medical Corp
    • 8.3.15.1. Company overview
    • 8.3.15.2. Financial performance
    • 8.3.15.3. Product benchmarking
    • 8.3.15.4. Strategic initiatives
    • 8.3.15.5. SWOT analysis
    • 8.3.15.6. Future developments/R&D trends
  • 8.3.16. Double Medical Technology Inc.
    • 8.3.16.1. Company overview
    • 8.3.16.2. Financial performance
    • 8.3.16.3. Product benchmarking
    • 8.3.16.4. Strategic initiatives
    • 8.3.16.5. SWOT analysis
    • 8.3.16.6. Future developments/R&D trends
  • 8.3.17. Bioconcept Dental Implants
    • 8.3.17.1. Company overview
    • 8.3.17.2. Financial performance
    • 8.3.17.3. Product benchmarking
    • 8.3.17.4. Strategic initiatives
    • 8.3.17.5. SWOT analysis
    • 8.3.17.6. Future developments/R&D trends
  • 8.3.18. Neoss Ltd
    • 8.3.18.1. Company overview
    • 8.3.18.2. Financial performance
    • 8.3.18.3. Product benchmarking
    • 8.3.18.4. Strategic initiatives
    • 8.3.18.5. SWOT analysis
    • 8.3.18.6. Future developments/R&D trends
  • 8.3.19. Southern Implants
    • 8.3.19.1. Company overview
    • 8.3.19.2. Financial performance
    • 8.3.19.3. Product benchmarking
    • 8.3.19.4. Strategic initiatives
    • 8.3.19.5. SWOT analysis
    • 8.3.19.6. Future developments/R&D trends
• 8.4. Heat Map Analysis/ Company Market Position Analysis
• 8.5. Estimated Company Market Share Analysis, 2024
• 8.6. List of Other Key Market Players